Cited by 15Amino Acid Enzymes and MetabolismMetabolism and Genetic DisordersTryptophan and brain disorders

Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia

Colombo, Jean-Pierre, Bachmann, Claude, Cervantes, Heidi, Kokorovic, Milica, Perritaz, Rachel·1996·Pediatric Research

Abstract

Hyperammonemia found in congenital disorders has a toxic effect on the central nervous system. Disturbances of brain neurotransmitter metabolism have been proposed, such as an increased transport of tryptophan into the brain and an increased flux through the serotonin pathway. Results concerning the catecholamine pathway are, however, contradictory. We therefore studied whether hyperammonermia increases brain uptake of the neurotransmitter precursor amino acid tyrosine and whether these changes affect the concentration of neurotransmitters and their metabolites in different brain areas (frontal cortex, caudatus-putamen, thalamus, hypothalamus, hippocampus/substantia nigra, brainstem) of rats made hyperammonemic with urease. The brain uptake of tyrosine was measured in the forebrain, brainstem, and cerebellum. The brain areas were analyzed for dopamine, 3,4-hydroxyphenylacetic acid; homovanillic acid, norepinephrine, and vanillylmandelic acid. The brain uptake index of tyrosine was increased in the forebrain and brainstem of the hyperammonemic rats with concomitantly elevated concentrations in the forebrain of tyrosine, phenylalanine, and tryptophan. The homovanillic acid content was significantly increased in the hypothalamus, hippocampus/substantia nigra and brainstem. The concentrations of norepinephrine, dopamine, and 3, 4-hydroxyphenylacetic acid were not significantly changed. Vanillylmandellic acid was decreased in the caudatus-putamen, thalamus, and hypothalamus. The d…

Integrity signals

Registry

Crossref · 10.1203/00006450-199606000-00017

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metabolites that were lower in 4s2M (riboflavin, benzaldehyde, 1-aminocyclopropane-1-carboxylic acid) are not primary intermediates of central carbon metabolism and changes in their abundance may reflect shifts in cofactor handling or dietary metabolite uptake rather than broad changes in core metabolic pathways.

    “Metabolites that were lower in 4s2M - riboflavin, benzaldehyde, and 1-aminocyclopropane-1-carboxylic acid – are not primary intermediates of central carbon metabolism and changes in their abundance may reflect shifts in cofactor handling or dietary metabolite uptake rather than broad changes in core metabolic pathways”

Cited by

Sorted by citations

Authors
Colombo, J.-P., Bachmann, C., Cervantes, H., Kokorovic, M., & Perritaz, R.
Affiliations
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of Bern (CH)
Venue
Pediatric Research
Published
1996-06
Volume
39
Issue
6
Pages
1036-1040
ISSN
  • 0031-3998 (ISSN-L)
  • 1530-0447
OpenAlex
W1997127065
Cited by
15
References
0
Citations by year
2026: 1 · 2024: 1 · 2017: 1 · 2013: 4
FWCI
0.42
Type
journal article
Language
en
Open access
closed
Locations
  • Pediatric Research (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
tyrosine uptake, blood-brain barrier, monoamine metabolism, dopaminergic pathways, homovanillic acid, vanillylmandelic acid, norepinephrine, catecholamines, neuropsychiatric disorders
MeSH terms
Amino Acids, Ammonia, Animals, Body Weight, Brain, Disease Models, Animal, Dopamine, Eating, Homovanillic Acid, Male, Norepinephrine, Tyrosine, Urease, Vanilmandelic Acid, Rats, Wistar, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review